Corrigendum: Case report: A novel intergenic MIR4299/MIR8070-RET fusion with RET amplification and clinical response to pralsetinib in a lung adenocarcinoma patient

Detalles Bibliográficos
Autores principales: Wang, Sha-Sha, Wang, Fang, Zeng, Zhen, Gao, Fang, Liu, Huan-Huan, Wang, Hui-Na, Hu, Yi, Qin, Hai-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793326/
https://www.ncbi.nlm.nih.gov/pubmed/36582807
http://dx.doi.org/10.3389/fonc.2022.1113289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793326/
https://www.ncbi.nlm.nih.gov/pubmed/36582807
http://dx.doi.org/10.3389/fonc.2022.1113289

Ejemplares similares